5 Compliance Lessons From Novartis' FCPA Settlement
On June 25, the U.S. Department of Justice announced a pair of deferred prosecution agreements with one current and one former subsidiary of Swiss pharmaceutical giant Novartis AG to resolve criminal...To view the full article, register now.
Already a subscriber? Click here to view full article